Trial Profile
Retrospective study of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 10 Sep 2018 New trial record